Trial · NCT03310580
Adverse events33
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 33
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Conjunctival hyperaemia | Eye disorders | AR-13324 Ophthalmic Solution 0.02% | 10 | 15 | 10 |
| other | Conjunctival hyperaemia | Eye disorders | AR-13324 Ophthalmic Solution 0.04% | 10 | 14 | 10 |
| other | Conjunctival hyperaemia | Eye disorders | Placebo Comparator | 0 | 12 | 0 |
| other | Eye Pruritus | Eye disorders | AR-13324 Ophthalmic Solution 0.02% | 0 | 15 | 0 |
| other | Eye Pruritus | Eye disorders | AR-13324 Ophthalmic Solution 0.04% | 2 | 14 | 2 |
| other | Eye Pruritus | Eye disorders | Placebo Comparator | 1 | 12 | 1 |
| other | Conjunctival hemorrhage | Eye disorders | AR-13324 Ophthalmic Solution 0.02% | 0 | 15 | 0 |
| other | Conjunctival hemorrhage | Eye disorders | AR-13324 Ophthalmic Solution 0.04% | 2 | 14 | 2 |
| other | Conjunctival hemorrhage | Eye disorders | Placebo Comparator | 0 | 12 | 0 |
| other | Dry eye | Eye disorders | AR-13324 Ophthalmic Solution 0.02% | 0 | 15 | 0 |
| other | Dry eye | Eye disorders | AR-13324 Ophthalmic Solution 0.04% | 1 | 14 | 1 |
| other | Dry eye | Eye disorders | Placebo Comparator | 1 | 12 | 1 |
| other | vision blurred | Eye disorders | AR-13324 Ophthalmic Solution 0.02% | 2 | 15 | 2 |
| other | vision blurred | Eye disorders | AR-13324 Ophthalmic Solution 0.04% | 0 | 14 | 0 |
| other | vision blurred | Eye disorders | Placebo Comparator | 0 | 12 | 0 |
| other | Eyelid margin crusting | Eye disorders | AR-13324 Ophthalmic Solution 0.02% | 0 | 15 | 0 |
| other | Eyelid margin crusting | Eye disorders | AR-13324 Ophthalmic Solution 0.04% | 1 | 14 | 1 |
| other | Eyelid margin crusting | Eye disorders | Placebo Comparator | 0 | 12 | 0 |
| other | Eyelids pruritus | Eye disorders | AR-13324 Ophthalmic Solution 0.02% | 0 | 15 | 0 |
| other | Eyelids pruritus | Eye disorders | AR-13324 Ophthalmic Solution 0.04% | 1 | 14 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03310580/events